Primary Hyperoxaluria

Abstract EN

Primary hyperoxalurias (PH) are inborn errors in the metabolism of glyoxylate and oxalate.

PH type 1, the most common form, is an autosomal recessive disorder caused by a deficiency of the liver-specific enzyme alanine, glyoxylate aminotransferase (AGT) resulting in overproduction and excessive urinary excretion of oxalate.

Recurrent urolithiasis and nephrocalcinosis are the hallmarks of the disease.

As glomerular filtration rate decreases due to progressive renal damage, oxalate accumulates leading to systemic oxalosis.

Diagnosis is often delayed and is based on clinical and sonographic findings, urinary oxalate assessment, DNA analysis, and, if necessary, direct AGT activity measurement in liver biopsy tissue.

Early initiation of conservative treatment, including high fluid intake, inhibitors of calcium oxalate crystallization, and pyridoxine in responsive cases, can help to maintain renal function in compliant subjects.

In end-stage renal disease patients, the best outcomes have been achieved with combined liver-kidney transplantation which corrects the enzyme defect.